Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Singer

Showing results (251-260 of 253) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 253 results.
Urologic Oncology|August 17, 2025
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think TankDaniel D Shapiro, Edwin Jason Abel, Laurence Albiges, et al.
The Lancet. Oncology|June 28, 2024
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 studyMohamad E Allaf, Se-Eun Kim, Viraj Master, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancerJenna H Newman, C Brent Chesson, Nora L Herzog, et al.
Pageof 26

Showing results (251-260 of 253) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 253 results.
Urologic Oncology|August 17, 2025
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think TankDaniel D Shapiro, Edwin Jason Abel, Laurence Albiges, et al.
The Lancet. Oncology|June 28, 2024
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 studyMohamad E Allaf, Se-Eun Kim, Viraj Master, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancerJenna H Newman, C Brent Chesson, Nora L Herzog, et al.
Pageof 26